Pro-Dex Inc(PDEX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 15.19 | EPS (ttm) | 4.14 | Insider Own | 37.37% | Shs Outstand | 3.2M | Perf Week | 1.71% |
| Market Cap | 0.20B | Forward P/E | 18.69 | EPS next Y | 8.74% | Insider Trans | -2.65% | Shs Float | 2.0M | Perf Month | -6.83% |
| Enterprise Value | 0.21B | PEG | - | EPS next Q | 0.67 | Inst Own | 31.78% | Short Float | 8.9% | Perf Quarter | -0.18% |
| Income | 0.01B | P/S | 2.59 | EPS this Y | -25% | Inst Trans | -0.71% | Short Ratio | 2.07 | Perf Half Y | 34.14% |
| Sales | 0.08B | P/B | 4.2 | EPS next 5Y | - | ROA | 19.7% | Short Interest | 0.18M | Perf YTD | 63.21% |
| Book/sh | 14.95 | P/C | 21.54 | EPS past 3/5Y | 28.41% 22.74% | ROE | 32.43% | 52W High | -18.44% ($77.00) | Perf Year | 78.5% |
| Cash/sh | 2.92 | P/FCF | 29.76 | Sales past 3/5Y | 18.94% 15.32% | ROIC | 22.21% | 52W Low | 167.6% ($23.47) | Perf 3Y | 280.41% |
| Dividend Est. | - | EV/EBITDA | 14.66 | EPS Y/Y TTM | 53.76% | Gross Margin | 31.87% | Volatility(W/M) | 9.01% 5.93% | Perf 5Y | 158.88% |
| Dividend TTM | - | EV/Sales | 2.72 | Sales Y/Y TTM | 16.45% | Oper. Margin | 16.75% | ATR (14) | 4.32 | Perf 10Y | 1096.29% |
| Dividend Ex-Date | - | Quick Ratio | 2.44 | EPS Q/Q | 142.71% | Profit Margin | 17.62% | RSI (14) | 48.53 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.1 | Sales Q/Q | 16.64% | SMA20 | -2.95% ($64.72) | Beta | 0.07 | Target Price | $74 |
| Payout | - | Debt/Eq | 0.4 | Earnings | 2026/9/3 | SMA50 | 1.01% ($62.18) | Rel Volume | 0.73 | Prev Close | $59.84 |
| Employees | 206 | LT Debt/Eq | 0.29 | EPS/Sales Surpr. | 29.85% 6.28% | SMA200 | 20.3% ($52.21) | Avg Volume(3M) | 0.09M | Price | $62.81 |
| IPO | 1986/8/7 | Option/Short | No/Yes | Trades | 1455 | Volume | 63,069 | Change | 4.95% |
Company
PDEX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔩 Pro-Dex (PDEX) is a U.S. medical device contract manufacturer that designs and produces autoclavable, battery- and electric-powered surgical drivers and shavers used in orthopedic and craniomaxillofacial procedures. Leveraging its proprietary torque-limiting technology, the company supplies critical surgical handpieces to major medical device OEM customers, and is distinguished by its vertically integrated capabilities that span the entire process from design through full-scale production.
Over the past 1 year, roughly in the middle
18% below its 1-year high.
PDEX makes money exceptionally well
16.75% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -25.0% this year.
Tap to view numbers
The stock looks undervalued
Trading at 15.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 1 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +280.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 31.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $201M.
FAQ
What kind of company is PDEX?
PDEX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of PDEX?
The market cap of PDEX is approximately $201M, ranking 4,118 within its sector.
What is the P/E ratio of PDEX?
PDEX has a P/E ratio of approximately 15.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PDEX?
PDEX has recorded a 52-week high of $77.00 and a low of $23.47.